CATENA, Cristiana
 Distribuzione geografica
Continente #
NA - Nord America 16.165
EU - Europa 5.066
AS - Asia 1.525
Continente sconosciuto - Info sul continente non disponibili 22
AF - Africa 11
SA - Sud America 7
OC - Oceania 3
Totale 22.799
Nazione #
US - Stati Uniti d'America 16.070
UA - Ucraina 1.819
IT - Italia 957
CN - Cina 760
DE - Germania 743
FI - Finlandia 604
SG - Singapore 459
IE - Irlanda 307
RU - Federazione Russa 213
SE - Svezia 185
TR - Turchia 162
CA - Canada 88
GB - Regno Unito 65
VN - Vietnam 54
BE - Belgio 37
FR - Francia 32
CZ - Repubblica Ceca 26
IN - India 25
EU - Europa 21
NL - Olanda 17
IR - Iran 14
ES - Italia 13
AT - Austria 12
KR - Corea 11
JP - Giappone 9
HK - Hong Kong 8
TG - Togo 7
TW - Taiwan 5
EE - Estonia 4
MX - Messico 4
PL - Polonia 4
RS - Serbia 4
AU - Australia 3
CH - Svizzera 3
IL - Israele 3
PH - Filippine 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BT - Bhutan 2
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
HR - Croazia 2
LT - Lituania 2
ME - Montenegro 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
BR - Brasile 1
DZ - Algeria 1
GL - Groenlandia 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NO - Norvegia 1
PA - Panama 1
TN - Tunisia 1
Totale 22.799
Città #
Woodbridge 2.091
Fairfield 1.829
Ann Arbor 1.474
Jacksonville 1.304
Houston 1.111
Chandler 975
Ashburn 844
Dearborn 788
Wilmington 782
Seattle 718
Cambridge 648
Boardman 431
Singapore 361
Princeton 336
Dublin 305
Beijing 296
Udine 169
Izmir 161
San Diego 128
Ottawa 78
Des Moines 74
Ogden 71
Hefei 64
Norwalk 64
Milan 63
Dong Ket 53
Nanjing 51
Kunming 49
Redmond 47
San Mateo 45
Helsinki 44
Rome 40
Guangzhou 38
Munich 30
Brussels 28
Grafing 25
Falls Church 24
Brno 22
Trieste 19
Washington 19
Jinan 18
New York 18
Shanghai 18
Fuzhou 13
Mcallen 13
Los Angeles 12
Codroipo 11
Indiana 11
Nanchang 11
Pignone 11
Hebei 10
Wuhan 10
Phoenix 9
Turin 9
Vienna 9
Espoo 8
Hyderabad 8
Saint Petersburg 8
Vicenza 8
Xian 8
Andover 7
Bitetto 7
Bologna 7
Changsha 7
Frankfurt am Main 7
Hangzhou 7
Leawood 7
Lomé 7
Naples 7
Palermo 7
Taranto 7
Venice 7
Baotou 6
Chongqing 6
Hong Kong 6
Lappeenranta 6
Nanning 6
Paris 6
Santa Clara 6
Shenyang 6
Simi Valley 6
Torre Del Greco 6
Zhengzhou 6
Ancona 5
Castellammare Di Stabia 5
Chengdu 5
Henderson 5
Lanzhou 5
London 5
Madrid 5
Taipei 5
Toronto 5
Venezia 5
Verona 5
Amsterdam 4
Augusta 4
Bari 4
Belgrade 4
Berlin 4
Catania 4
Totale 16.151
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 239
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 161
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 146
Aldosterone and the heart: from basic research to clinical evidence 145
Aldosterone and Left Ventricular Remodeling 141
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 139
Abnormalities of insulin receptors in spontaneously hypertensive rats 136
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data 135
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism 133
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 129
Aldosterone and the heart: still an unresolved issue? 128
Aldosterone, Organ Damage, and Dietary Salt 126
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 124
Effects of angiotensin II (ANG II) infusion on insulin receptor binding and gene expression in the kidney of normal and diabetic rats 123
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 122
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 122
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 121
Abnormalities of glucose metabolism in patients with early renal failure 120
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 120
The emergent cardiovascular risk factors and organ damage in arterial hypertension 119
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 119
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 118
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 117
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance 117
Prohypertensive effect of insulin: possible role of the sympathetic system 116
Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats 116
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 116
Treatment of primary aldosteronism and organ protection 116
Predictors of target-organ damage in hypertension: role of lipoprotein(a) [Lp(a)] and apo(a) isoforms 115
Benzodiazepines: an old class of new antihypertensive drugs? 115
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 115
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 114
Kidney in primary aldosteronism: a key determinant of treatment outcome 113
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal 113
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 112
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 112
Spontaneous restoration of sinus rhythm after cardiac surgery 112
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 112
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 111
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: Results from the MINISAL-SIIA study program 110
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients 109
Benign familial macrocytosis 109
Salt, hypertension, and cardiovascular disease 109
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 109
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 107
Cardiovascular outcomes in patients with primary aldosteronism after treatment 107
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 107
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. 106
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 106
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 106
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 105
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 105
Diabetes, diabetic complications, and blood pressure targets 104
Autonomic dysfunction in hyperadrenergic orthostatic hypotension 104
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 103
Potassium-sparing diuretics in hypertension 103
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 103
The SPARTACUS Trial: Controversies and Unresolved Issues 103
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 103
Renal function in primary aldosteronism 102
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 102
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 102
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 101
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 101
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 101
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 101
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension 99
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 99
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 99
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 98
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 97
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study 97
Glucose metabolism in early renal failure 96
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 96
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 96
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort 96
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 95
Uricaemia and left ventricular mass in hypertensive patients 95
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 94
NON-ALCOHOLIC FATTY LIVER DISEASE IS NOT ASSOCIATED WITH VITAMIN D DEFICIENCY IN ESSENTIAL HYPERTENSION 93
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 93
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial 93
Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension 92
Low serum 25-hydroxyvitamin D levels are associated with left ventricular hypertrophy in essential hypertension 92
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 92
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 92
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 92
Oxidative Stress Is Activated by Free Fatty Acids in Cultured Human Hepatocytes 92
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 91
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 91
Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension 91
Response to "plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro-and Cardiovascular Diseases in the Metabolic Syndrome" 91
Increased serum lipoprotein(a) levels in patients with early renal failure 90
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 90
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: The EPATH trial 90
Primary hyperparathyroidism in pregnancy 90
Renal hyperfiltration and increased prevalence of cystic disease in patients with primary aldosteronism 89
Associazione dell’ispessimento miointimale carotideo con uno stato protrombotico in pazienti ipertesi 89
Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era 89
Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients 89
Totale 10.904
Categoria #
all - tutte 89.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.967 0 0 0 0 0 1.098 706 731 379 502 108 443
2020/20213.703 107 394 93 497 97 497 198 431 642 131 432 184
2021/20222.474 103 289 98 182 69 88 145 160 26 414 474 426
2022/20232.604 371 118 36 299 234 781 11 166 377 49 88 74
2023/2024870 141 72 55 42 167 93 26 21 105 34 9 105
2024/20251.304 141 420 174 184 116 269 0 0 0 0 0 0
Totale 23.654